These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29802412)

  • 1. The histamine H
    Kotańska M; Kuder KJ; Szczepańska K; Sapa J; Kieć-Kononowicz K
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Aug; 391(8):875-881. PubMed ID: 29802412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KSK19 - Novel histamine H3 receptor ligand reduces body weight in diet induced obese mice.
    Kotańska M; Mika K; Reguła K; Szczepańska K; Szafarz M; Bednarski M; Olejarz-Maciej A; Nowak K; Latacz G; Mogilski S; Kuder KJ; Kieć-Kononowicz K; Sapa J
    Biochem Pharmacol; 2019 Oct; 168():193-203. PubMed ID: 31295465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-obesity effect of rimonabant is associated with an improved serum lipid profile.
    Poirier B; Bidouard JP; Cadrouvele C; Marniquet X; Staels B; O'Connor SE; Janiak P; Herbert JM
    Diabetes Obes Metab; 2005 Jan; 7(1):65-72. PubMed ID: 15642077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pitolisant protects mice chronically treated with corticosterone from some behavioral but not metabolic changes in corticosterone-induced depression model.
    Kotańska M; Mika K; Sałaciak K; Wheeler L; Sapa J; Kieć-Kononowicz K; Pytka K
    Pharmacol Biochem Behav; 2020 Sep; 196():172974. PubMed ID: 32565240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H3 histamine receptor antagonist pitolisant reverses some subchronic disturbances induced by olanzapine in mice.
    Dudek M; Kuder K; Kołaczkowski M; Olczyk A; Żmudzka E; Rak A; Bednarski M; Pytka K; Sapa J; Kieć-Kononowicz K
    Metab Brain Dis; 2016 Oct; 31(5):1023-9. PubMed ID: 27216278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NESS038C6, a novel selective CB1 antagonist agent with anti-obesity activity and improved molecular profile.
    Mastinu A; Pira M; Pani L; Pinna GA; Lazzari P
    Behav Brain Res; 2012 Oct; 234(2):192-204. PubMed ID: 22771813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sericin as treatment of obesity: morphophysiological effects in obese mice fed with high-fat diet.
    Kunz RI; Capelassi AN; Alegre-Maller ACP; Bonfleur ML; Ribeiro LFC; Costa RM; Natali MRM
    Einstein (Sao Paulo); 2020; 18():eAO4876. PubMed ID: 31576909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pitolisant, a histamine H3 inverse agonist, in drug-resistant idiopathic and symptomatic hypersomnia: a chart review.
    Leu-Semenescu S; Nittur N; Golmard JL; Arnulf I
    Sleep Med; 2014 Jun; 15(6):681-7. PubMed ID: 24854887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disodium Ascorbyl Phytostanyl Phosphates (FM-VP4) reduces plasma cholesterol concentration, body weight and abdominal fat gain within a dietary-induced obese mouse model.
    Looije NA; Risovic V; Stewart DJ; Debeyer D; Kutney J; Wasan KM
    J Pharm Pharm Sci; 2005 Aug; 8(3):400-8. PubMed ID: 16401390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aqueous extract of Chrysobalanus icaco leaves, in lower doses, prevent fat gain in obese high-fat fed mice.
    White PA; Cercato LM; Batista VS; Camargo EA; De Lucca W; Oliveira AS; Silva FT; Goes TC; Oliveira ER; Moraes VR; Nogueira PC; De Oliveira E Silva AM; Quintans-Junior LJ; Lima BS; Araújo AA; Santos MR
    J Ethnopharmacol; 2016 Feb; 179():92-100. PubMed ID: 26723470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic benefits of novel histamine H
    Mika K; Szafarz M; Bednarski M; Kuder K; Szczepańska K; Pociecha K; Pomierny B; Kieć-Kononowicz K; Sapa J; Kotańska M
    Biomed Pharmacother; 2021 Oct; 142():111952. PubMed ID: 34325303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a fat substitute, sucrose polyester, on food intake, body composition, and serum factors in lean and obese Zucker rats.
    Grossman BM; Akoh CC; Hobbs JK; Martin RJ
    Obes Res; 1994 May; 2(3):271-8. PubMed ID: 16353428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B Vitamins Can Reduce Body Weight Gain by Increasing Metabolism-related Enzyme Activities in Rats Fed on a High-Fat Diet.
    Zheng Y; Ma AG; Zheng MC; Wang QZ; Liang H; Han XX; Schouten EG
    Curr Med Sci; 2018 Feb; 38(1):174-183. PubMed ID: 30074168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidiabetic properties of the histamine H3 receptor protean agonist proxyfan.
    Henry MB; Zheng S; Duan C; Patel B; Vassileva G; Sondey C; Lachowicz J; Hwa JJ
    Endocrinology; 2011 Mar; 152(3):828-35. PubMed ID: 21239440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiobesity effects of yerba maté extract (Ilex paraguariensis) in high-fat diet-induced obese mice.
    Arçari DP; Bartchewsky W; dos Santos TW; Oliveira KA; Funck A; Pedrazzoli J; de Souza MF; Saad MJ; Bastos DH; Gambero A; Carvalho Pde O; Ribeiro ML
    Obesity (Silver Spring); 2009 Dec; 17(12):2127-33. PubMed ID: 19444227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic oral rapamycin decreases adiposity, hepatic triglycerides and insulin resistance in male mice fed a diet high in sucrose and saturated fat.
    den Hartigh LJ; Goodspeed L; Wang SA; Kenerson HL; Omer M; O'Brien KD; Ladiges W; Yeung R; Subramanian S
    Exp Physiol; 2018 Nov; 103(11):1469-1480. PubMed ID: 30117227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmenting leptin circadian rhythm following a weight reduction in diet-induced obese rats: short- and long-term effects.
    Buison A; Pellizzon M; Ordiz F; Jen KL
    Metabolism; 2004 Jun; 53(6):782-9. PubMed ID: 15164329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Niclosamide as an anti-obesity drug: an experimental study.
    Al-Gareeb AI; Aljubory KD; Alkuraishy HM
    Eat Weight Disord; 2017 Jun; 22(2):339-344. PubMed ID: 28271456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent access to a sucrose solution impairs metabolism in obesity-prone but not obesity-resistant mice.
    Soto M; Chaumontet C; Mauduit CD; Fromentin G; Palme R; Tomé D; Even P
    Physiol Behav; 2016 Feb; 154():175-83. PubMed ID: 26596703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical evaluation of the abuse potential of Pitolisant, a histamine H₃ receptor inverse agonist/antagonist compared with Modafinil.
    Uguen M; Perrin D; Belliard S; Ligneau X; Beardsley PM; Lecomte JM; Schwartz JC
    Br J Pharmacol; 2013 Jun; 169(3):632-44. PubMed ID: 23472741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.